Occam Expands Its European Practice with CFO Placement
In early 2025, Occam Global placed McDavid Stilwell as CFO of CPTx, a company pioneering the development of in vivo genetic medicines built on single-stranded DNA. CPTx’s lead development programs include a next-generation in vivo CAR-T therapy and a novel, programmable, non-viral self-delivering gene nanocarrier.
Stilwell is an industry veteran with more than 25 years of experience in finance, corporate development, investor relations, and communications. Previously, he served as CFO at Coherus Biosciences as the company launched multiple new products into the US market. Earlier in his career, he held leadership roles at Sangamo Therapeutics, a pioneer in gene editing, and several other biotech companies.
Stilwell received a BA from St. John’s College and an MBA from Harvard Business School.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.